company

National Alliance for Research in Schizophrenia and Affective Disorders

as of 2026-07-01
Monitor thisAsk about this
at a glance
1 trials sponsored · 2 assets in the graph
Synthesized from structured facts only — each point cited above.

Financials

SEC EDGAR XBRL · latest period per metric
No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).

Pipeline

2 assets
OxytocinSocial Cognitive skills training

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
asset
Oxytocin
OTHER
drug
Social Cognitive skills training
BEHAVIORAL
drug